全球mRNA療法市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

全球mRNA療法市場預計將從2025年的215.2億美元成長至2034年的906億美元，2026年至2034年的複合年成長率（CAGR）為17.32%。全球mRNA療法市場正經歷快速成長，這主要得益於傳訊RNA技術的進步及其在治療多種疾病方面的潛力。 mRNA療法透過將遺傳訊息傳遞給細胞，使其產生特定的蛋白質，從而幫助預防或治療疾病。近年來，這種創新方法備受關注，尤其是在疫苗研發領域取得了成功。

生技公司和研究機構正在探索基於mRNA的療法，用於治療癌症、遺傳性疾病和感染疾病等。 mRNA技術的柔軟性使科學家能夠快速設計療法並針對特定的疾病機制。遞送系統（例如脂質奈米顆粒）的進步也提高了基於mRNA的療法的穩定性和療效。

隨著臨床研究不斷證實mRNA療法的潛力，市場預計將持續擴張。製藥公司正大力投資開發利用該技術的新型治療應用。隨著生物技術的進步，mRNA療法將在下一代醫學中發揮至關重要的作用。

我們的報告經過精心撰寫，旨在提供涵蓋廣泛行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵組成部分，旨在幫助您全面了解市場環境：

市場概覽：本節對市場進行了清晰的說明，包括關鍵定義、分類以及當前行業格局的概述。

市場動態：對影響市場成長的關鍵促進因素、阻礙因素、機會和挑戰進行詳細評估。這包括技術發展、法律規範和不斷變化的行業趨勢等因素。

市場區隔分析：本部分根據產品類型、應用、最終用戶和地區將市場系統性地分類為若干關鍵細分市場。本部分揭示了每個細分市場的表現、成長潛力和市場貢獻。

競爭格局：我們對主要市場參與企業進行了詳細評估，包括其市場定位、產品系列、策略舉措和財務表現。這有助於深入了解競爭趨勢和主要參與者所採取的策略。

市場預測：本部分提供基於數據的市場規模和成長模式預測，預測期為特定時期。它綜合考慮了歷史趨勢、當前市場狀況和定量分析，以識別未來預期趨勢。

區域分析：這包括對主要地理區域的市場表現進行全面檢驗，確定高成長領域和區域趨勢，以更深入地了解每個區域特有的市場機會。

新趨勢與新機會：識別關鍵市場趨勢、技術進步和新興投資機會。本部分重點在於潛在成長領域和未來產業趨勢。

客製化選項：我們提供靈活的報告客製化服務，以滿足您的特定需求。這包括額外的細分、國家/地區分析、競爭對手分析、客製化資料點或針對特定細分市場的洞察，以更好地支援您的策略決策。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球mRNA治療市場：依應用領域分類

• 市場分析、洞察與預測
• 感染疾病
• 腫瘤學
• 罕見遺傳疾病
• 呼吸系統疾病
• 其他

第5章 全球mRNA治療市場：依類型分類

• 市場分析、洞察與預測
• 為了預防
• 治療

第6章：全球mRNA治療市場：依最終用途分類

• 市場分析、洞察與預測
• 醫院和診所
• 研究機構
• 其他

第7章 全球mRNA治療市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 中國
  • 日本
  • 韓國
  • 印度
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Moderna
  • BioNTech
  • Arcturus Therapeutics
  • CureVac
  • Translate Bio/Sanofi
  • Ethris
  • Arcturus
  • Capstan Therapeutics
  • ReNAgade Therapeutics
  • Strand Therapeutics
  • Replicate Bioscience
  • ETheRNA
  • Tiba Biotech
  • Acuitas Therapeutics
  • Beam Therapeutics
  • Intellia Therapeutics
  • Moderna Therapeutics
  • Cartesian Therapeutics
  • Sana Biotechnology
  • Orbimed-backed MRNA Developers

The global mRNA therapeutics market size is expected to reach USD 90.60 Billion in 2034 from USD 21.52 Billion in 2025, growing at a CAGR of 17.32% during 2026-2034.The global mRNA therapeutics market is experiencing rapid growth due to advancements in messenger RNA technology and its potential to treat a wide range of diseases. mRNA therapeutics work by delivering genetic instructions to cells, enabling them to produce specific proteins that can prevent or treat diseases. This innovative approach has gained significant attention in recent years due to its success in vaccine development.

Biotechnology companies and research institutions are exploring mRNA-based treatments for conditions such as cancer, genetic disorders, and infectious diseases. The flexibility of mRNA technology allows scientists to design therapies quickly and target specific disease mechanisms. Advances in delivery systems, such as lipid nanoparticles, are also improving the stability and effectiveness of mRNA therapeutics.

In the future, the market is expected to grow as clinical research continues to demonstrate the potential of mRNA-based treatments. Pharmaceutical companies are investing heavily in developing new therapeutic applications using this technology. As biotechnology innovation progresses, mRNA therapeutics are likely to become an important part of next-generation medical treatments.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Application

• Infectious Diseases
• Oncology
• Rare Genetic Diseases
• Respiratory Diseases
• Others

By Type

• Prophylactic
• Therapeutic

By End-use

• Hospitals & Clinics
• Research Organizations
• Others

COMPANIES PROFILED

• Moderna, BioNTech, Arcturus Therapeutics, CureVac, Translate Bio/Sanofi, Ethris, Arcturus, Capstan Therapeutics, ReNAgade Therapeutics, Strand Therapeutics, Replicate Bioscience, eTheRNA, Tiba Biotech, Acuitas Therapeutics, Beam Therapeutics, Intellia Therapeutics, Moderna Therapeutics, Cartesian Therapeutics, Sana Biotechnology, Orbimed-backed mRNA developers

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL MRNA THERAPEUTICS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Application
• 4.2. Infectious Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Oncology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Rare Genetic Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Respiratory Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL MRNA THERAPEUTICS MARKET: BY TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Type
• 5.2. Prophylactic Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Therapeutic Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL MRNA THERAPEUTICS MARKET: BY END-USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-use
• 6.2. Hospitals & Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Research Organizations Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL MRNA THERAPEUTICS MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Application
  • 7.2.2 By Type
  • 7.2.3 By End-use
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Application
  • 7.3.2 By Type
  • 7.3.3 By End-use
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Spain
  • 7.3.9 Russia
  • 7.3.10 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Application
  • 7.4.2 By Type
  • 7.4.3 By End-use
  • 7.4.4 China
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 India
  • 7.4.8 Australia
  • 7.4.9 South East Asia
  • 7.4.10 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Application
  • 7.5.2 By Type
  • 7.5.3 By End-use
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Application
  • 7.6.2 By Type
  • 7.6.3 By End-use
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL MRNA THERAPEUTICS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Moderna
  • 9.2.2 BioNTech
  • 9.2.3 Arcturus Therapeutics
  • 9.2.4 CureVac
  • 9.2.5 Translate Bio/Sanofi
  • 9.2.6 Ethris
  • 9.2.7 Arcturus
  • 9.2.8 Capstan Therapeutics
  • 9.2.9 ReNAgade Therapeutics
  • 9.2.10 Strand Therapeutics
  • 9.2.11 Replicate Bioscience
  • 9.2.12 ETheRNA
  • 9.2.13 Tiba Biotech
  • 9.2.14 Acuitas Therapeutics
  • 9.2.15 Beam Therapeutics
  • 9.2.16 Intellia Therapeutics
  • 9.2.17 Moderna Therapeutics
  • 9.2.18 Cartesian Therapeutics
  • 9.2.19 Sana Biotechnology
  • 9.2.20 Orbimed-backed MRNA Developers